Optical Tympanostomy Tube' for prevention and treatment of tympanostomy tube otorrhea08/01/2022 - 08/31/2024 (Subcontract PI)
PI:
Stephen I. Pelton, MDMassachusetts General Hospital NIH NIDCD5R21DC019958-02
Interactions of Streptococcus pneumoniae and Non-typeable Haemophilus influenzae and the developm…10/01/2019 - 07/31/2024 (PI)
Merck
SARS-CoV-2 disruption of Nasopharyngeal Microbiome: Impact on Pneumococcal Prevalence, Density and Serotype Distribution04/08/2021 - 07/01/2024 (PI)
Merck
Protocol No. M14-74805/01/2015 - 07/31/2023 (PI)
AbbVie Inc.
Development of innovative therapeutics for otitis media04/01/2019 - 03/31/2023 (Subcontract PI)
PI:
Stephen I. Pelton, MDGeorgia State University NIH NIDCD5R01DC015557-05
IMPAACT 2017 – Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents01/01/2019 - 12/31/2022 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University NIH NIAID
The serotype epidemiology and antibiotic resistance of Streptococcus pneumonia…12/20/2019 - 09/30/2022 (Subcontract PI)
PI:
Stephen I. Pelton, MDDuke University Merck
Safety of Recombinant Influenza Vaccine(Flublok) in Pregnant Women09/15/2018 - 09/14/2022 (PI)
Centers for Disease Control and Prevention/DHHS
Ryan White Title IV Women, Infant, Children, Youth and Affected Family Members AIDS Healthcare08/01/2017 - 07/31/2022 (PI)
HIV/AIDS Bureau/HRSA/DHHS
Sanofi NTHi Vaccine Program-Pelton Lab Collaboration
02/03/2021 - 03/31/2022 (PI)
Sanofi Pasteur
Ryan White Medical Transportation03/01/2020 - 02/28/2022 (PI)
Boston Public Health Commission
Ryan White Treatment and Modernization Act, Part A03/01/2020 - 02/28/2022 (PI)
Boston Public Health Commission
Ryan White Medical Case Management (Part A)03/01/2012 - 02/28/2022 (PI)
PHC HRSA
NICHD International Domestic Pediatric and Maternal HIV Studies Coordinating Center09/01/2014 - 12/31/2021 (Subcontract PI)
PI:
Stephen I. Pelton, MDWESTAT NIH
LOC-IMPAACT Leadership Group - Protocol IMPAACT 201812/01/2019 - 11/30/2021 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University NIH NICHD
IMPAACT Leadership -PTCL 13 - COVID 19
12/01/2019 - 11/30/2021 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University NIH NICHD
IMPAACT 2014: Phase I/II Study of the Pharmacokinetics, Safety and Tolerability of Doravirine…03/01/2018 - 07/31/2021 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University Merck
Trans-tympanic delivery of antibiotics07/22/2016 - 06/30/2021 (Subcontract PI)
PI:
Stephen I. Pelton, MDBoston Children's Hospital NIH NIDCD1R01DC015050-01A1
Ryan White HIV/AIDS Program Part D WICY COVID-19 Response04/01/2020 - 03/31/2021 (PI)
HIV/AIDS Bureau/HRSA/DHHS
RWAHP Part A COVID-19 CARES Act supplemental funding04/01/2020 - 03/31/2021 (Subcontract PI)
PI:
Stephen I. Pelton, MDBoston Public Health Commission HHS HRSA HAB
RWPA QI Mini Grant03/01/2019 - 02/28/2021 (Subcontract PI)
PI:
Stephen I. Pelton, MDBoston Public Health Commission HHS HRSA
Pneumonia Biology01/11/2017 - 12/31/2020 (Subcontract PI)
PI:
Stephen I. Pelton, MDTrustees of Boston University, BUMC NIH NHLBI
LOC-IMPAACT Leadership Group - COVID funding09/07/2020 - 11/30/2020 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University NIH NICHD5UM1AI068632-14
Macrophage protection in pneumococcal pneumonia08/20/2016 - 07/31/2019 (PI)
Trustees of Boston University NIH-NIAID
LOC-IMPAACT Leadership Group - Core Protocol Funds12/01/2017 - 11/30/2018 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University NIH NICHD5UM1AI068632-12
IMPAACT 2014 CORE12/01/2017 - 11/30/2018 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University NIH NICHD5UM1AI068632-12
IMPAACT 2017 CORE12/01/2017 - 11/30/2018 (Subcontract PI)
PI:
Stephen I. Pelton, MDJohns Hopkins University NIH NICHD5UM1AI068632-12
RWCA - Primary Care PHC 157006703/01/1998 - 11/30/2018 (PI)
PHC HRSA
Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis07/15/2015 - 12/31/2017 (PI)
NIH-NIDCD1R21DC014323-01A1
Post-PCU Pneumococcal Population Genetics and Resistance08/01/2006 - 07/31/2016 (PI)
Harvard Pilgrim Health Care (HPHC) NIH-NIAID
Evaluation of a Revised Formulation of Amoxicilin-Clavulanate05/01/2013 - 12/31/2015 (PI)
Laurel Pharmaceuticals, Inc
Evaluation of Solithromycin (CEM-101) dosing regimen for the Chinchilla10/01/2012 - 12/31/2015 (PI)
Cempra Pharmaceuticals Inc.
Evaluation of PCV15 against EOM due to vaccine serotypes 3, 19A & 22F03/26/2012 - 12/31/2015 (PI)
Merck
NICHD International and Domestic Pediatric and Maternal HIV Studies Coordinating Center12/01/2012 - 04/30/2015 (PI)
Children's Hospital NIH-NIDDK
Evaluation of IC47 Vaccine for Prevention of EOM Following Intranasal Immunization10/01/2010 - 12/31/2013 (PI)
Intercell AG
Impact of Serotype Replacement in the Nasopharynx on the Frequency of Pneumococcal AOM02/23/2009 - 12/31/2013 (PI)
Wyeth Pharmaceuticals
Boston Pediatric/Prenatal HIV/AIDS NICHD Network Site Proposal12/01/2007 - 11/30/2013 (PI)
Children's Hospital NIH-NICHD
Evaluation of GSK Vaccine Candidates Against Strep Pneumo Serotype 15C in a Chinchilla Model10/01/2010 - 12/31/2012 (PI)
GlaxoSmithKline
Natural History and Prevention of Experimental Otitis Media due to Streptococcus Pneumonaie11/15/2009 - 12/31/2012 (PI)
Novartis Pharma Corp
Streptococcus penumoniae: herd effects and emergence of potentially virulent serotypes04/01/2010 - 09/30/2012 (PI)
Thrasher Research Fund
(Bpap) Pediatric Aids Project08/01/2001 - 07/31/2012 (PI)
Dimock Comm Hlth Ctr HRSA-MCHB
Xylitol syrup for the prevention of acute otitis media in otitis-prone children02/01/2010 - 06/30/2012 (PI)
Arbor Pharmaceuticals, Inc.
Molecular Epidemiologic Identification of Pneumococcal Tissue Specific Genes04/01/2007 - 03/31/2012 (PI)
Yale University NIH-NIA
Development of Safe and Effective Novel Transtympanic Membrane Strategy for Treatment of Acute Bacte02/01/2009 - 12/31/2011 (PI)
CIMIT DOD-USAMRAA
Prevenar (6096A1) pneumococcal 7-valent conjugate vaccine04/15/2010 - 09/30/2011 (PI)
Wyeth Pharmaceuticals
Xylitol Syrup for the prevention of acute otitis media in media-prone children09/17/2009 - 08/31/2011 (PI)
Children's Hospital NIH-NIDCD
IMPAACT - T00411/27/2009 - 11/26/2010 (PI)
Social & Scientific Systems Inc. NIH-NIAID
IMPAACT - T00511/27/2009 - 11/26/2010 (PI)
Social & Scientific Systems Inc. NIH-NIAID
IMPAACT - T00611/27/2009 - 11/26/2010 (PI)
Social & Scientific Systems Inc. NIH-NIAID
Evaluation of a NO for Prevention and Treatment of AOM due to SP and NTHI04/01/2008 - 12/31/2009 (PI)
Enox Biopharma, Inc.
PACT 1061 (assays)09/15/2005 - 12/31/2009 (PI)
Social & Scientific Systems Inc. NIH-NIAID
Aids Clinical Trial Group03/01/1997 - 02/29/2008 (PI)
Children's Hospital NIH-NIAID
Evaluation of a Novel Antibacterials in the Treatment of Experim11/12/2003 - 12/31/2007 (PI)
Arpida
Surveillance for Staphylococcus aureus in eight Massachusetts Community07/01/2006 - 06/30/2007 (PI)
Harvard Pilgrim Health Care (HPHC)
Eval of a Novel Antibacterial Peptide Deformylase10/20/2003 - 04/30/2006 (PI)
Novartis Pharma Corp
Pulse Dosing in a Chinchilla Model of EOM Due to SI and NTHI05/01/2005 - 03/31/2006 (PI)
Advancis Pharmaceutical Corp
Reducing Antimicrobial Resistance: A Randomized Trial09/30/2003 - 09/29/2005 (PI)
Harvard Pilgrim Health Care (HPHC) DHHSR01 HS010247-05
Intervention Epidemiologic Research Studies of HIV/AIDS09/30/2003 - 09/29/2005 (PI)
UMASS NIH
Evaluation of an LPS Based Conjugate for the Promotion03/17/2003 - 07/31/2005 (PI)
Apovia Inc
PACTG P102412/01/2001 - 09/30/2004 (PI)
Social & Scientific Systems Inc. NIH-NIAIDU01 A141089
Pediatric AIDS Emergency Assistance Prog01/01/1992 - 01/31/2004 (PI)
E Glaser AIDS Fdn
Actg Protocol 24711/01/1997 - 06/30/2003 (PI)
WESTAT NIH-NIDCDN01-HD-3-3162
Epidemiology Of Hepatitis C Vi04/01/2000 - 08/31/2001 (PI)
DPH
Ceftriazone Vs. Ceftizoxime01/01/1992 - 06/30/2000 (PI)
Roche Laboratories
Chinchilla Om Study01/01/1992 - 06/30/2000 (PI)
Roche Laboratories
Pediatrics Aids Patient Suppor01/01/1992 - 06/30/2000 (PI)
Ped AIDS Charity Tr
Ceftruaxone In The Chinchilla01/01/1992 - 05/31/2000 (PI)
Roche Laboratories